Nick, you, the thank joining and Thank you today. call for all
strengthening with characterize recent well ahead. uncertainties systems and that investment in on the a some investment with of capabilities, and made teammates, year, positioned we highlighted We great benefits past platform. we our business the the our few past of over the the that multiyear our reduction revealed and ultimately we're As continued and the the in stronger reflect for XXXX us .
External momentum financial risk resilience years years. and years began XXXX performance our of challenges early our believe in
drugs. our guidance, our GLP-X annual Kidney integrated cover briefly Today, and continue and I results XXXX discussion provide Care will XXXX an our on on update
outstanding begin to the More This will do to I strived the and however, clinical to hours which XXX,XXX we highest give achieving XX a of communities, to committed step that XXXX, marks over a service means always year of also care only a our our back. cumulative second. XX,XXX be not their with first ever call, logged XXXX. First, have our teammates hours but as providing and than community we we're In highlights. years toward by company goal
tour, special kidney advance population communities symptoms wrapped which our program and And Today, of our teammates recently of time for often country. goal raising kidney until has our some XXXX severe. become personal a our health awareness We health the untreated their supporting mobile XX% goes undiagnosed U.S. screening of to kidney across disease. local and education disease, donated care
may tour help diabetes, health pressure was obesity, Our history that mobile factors identify and to designed high blood chronic risk including lead of kidney disease, disease. to for kidney family screening
our in teammates our X X bus power in service detection this XX,XXX hours of than more states. early dedication on to screenings tour, awareness To communities of volunteered prevention a effort road, the free communities. offer service across For kidney to months to miles and example XXX is of our raising for commitment XX their This disease. X,XXX wonderful local to ongoing combining with our traveled
came income, to EPS above adjusted the flow Transitioning free well beginning of year our guidance performance. Full operating in from all and our cash year. the XXXX adjusted
labor throughout year. XXXX challenges environment guidance the think would I XXXX. We reflect our that helpful to the uncertain over an volume on context, continue and shared progress our in began assumptions it's As back in and
initiatives on those facing. financial of headwinds we executing developing a simultaneously number on were some and focused of We're offsetting
on into points we These consistent to XX% a early the growth progressed, the impact As operating XX% target in range. a saw in in back improved income, combined year year-over-year strong operating ultimately adjusted trends, data positive our adjusted growth implemented, and return turned encouraging resulted positive performance of ratio the trends. the the leverage which the we initiatives in with EPS, and year,
share color. I'll additional X points for
First, on headwind been with surges these that in XXXX first landing growth X% then, was entered new volume. the annualization together, we year-over-year, able census the produce quarters same with started, due at lower growth were in of time, increased of Since and X successive since flat the consecutive from the prior COVID Adding magnitude top At guidance our a approximately volume saw XXXX factors excess patient with for mortality to year-over-year mortality. admits. We have to time year. patient COVID range. weaker
was Second, on We than in our reliance XXXX. than XXXX improved performance cut our labor more labor quickly staffing anticipated contract better centers. our and in
the teammate side with labor On of in turnover has the ledger, the care other markets. remained strong health elevated line
costs ahead. and retention for years training improvement improved the in an opportunity forward, represent Looking
these we treatment U.S. performance per initiatives notably, related spend year executed pharmaceutical from and Third, our drove strong in against facility through while revenue Most reducing our days full to for consolidated sustainable an more XX invested our day sales the Adding our platform to to achieve our capabilities. in improvements footprint. This differentiated outstanding. $X.XX additional revenue independent collections. and of our in than further this, operations operating trends, in we we resulted cost-saving
I cover moment. our we detail for Kidney a in which will in profitability annual more Finally, exceeded targets Care, Integrated
To we since and summarize, XXXX. with start in XXXX the had visibility more have of COVID we confidence entered that
operational has and us ahead. of the systems, years for Our challenges few well positioned ability to invest despite people, years, and in the last financial our the process
business, note, will or transition value-based let Kidney Integrated that Care IKC. which to call me we On care our
on quarterly than results. We have investors consistently urged assess our rather basis this business our to focusing on an annual
Now time reflect outlook performance is a and IKC. pause good our and of on to
more our or patients per programs, represents level, costs; based medical member our management. performance cost and a detail. through X our per At total on growth; month high IKC which G&A, of indicates medical reducing model in spend a each on three, bit IKC and assess total one, effectiveness two, and walk metrics: care which expense in we performance I'll primary clinical of
First, grew total to patients care for approximately growth patients of our reflecting a XX% represents XX% programs expense XX,XXX billion, from year-end, $X.X of as medical This IKC year-over-year. in increase XXXX.
programs, our disciplined, value-based continue prioritizing Then to growth. traditional be care we profitable
excess covered For XXXX, of for in and growth we expect medical total expense lives. XX%
healthier care proven collaboration driver expectations. partners to lives prevent rate is hospitalizations, of in care patients that model Largest acuity teams patients. physician readmission efforts of year-over-year reflecting has reducing This reduction and rates. of and our is our especially a and helping complex net on our in between Second, the in ahead most needs our costs, medical rising vulnerable slightly address and lead effective relies our savings our
finally, the result per per member per program In leverage. month And X%. cost our month and declined member to of improved cost fixed XXXX, per as cost continue down growth a trend our by
We to cost approximately expect XXXX. per decline in month further member per XX% by
of XXXX. we or we result XXXX by outperformed these that on breakeven efforts to performance operating better and The our is adjusted track deliver remain believe loss we forecast,
focused Medicare on business: patients. fee-for-service can on X special further Beyond based portfolio break CKCC Advantage primarily components IKC demonstration our Medicare and value-based performance care the patients, our of need primary metrics, for down our the our plans, core we project
care, consistent Special MA expect represents years further that year-over-year CKCC, We care we improvements optimize Within adjust Keep component, many model XXXX our our of value-based from and this CMS profitability. approximately of contracts savings, become Plans reached XX% in that have to and of census. and profitable in investment after the frame. in cost the our Need mind third portfolio, now changes time program
be our changed since Shortly we thinking I'll released. after our Before get a for call, were select quick clear, of none last clinical offer earnings has XXXX, on our GLP-X. results into trial the comment To call.
in benefits As XX% including confirms expected, cardiovascular mortality. in obesity and disease, trial reduction a the people with certain all-cause cardiovascular
Next on FLOW disease. endpoints, efficacy will multiple horizon the the will the progression near-term on slowing anticipate chronic which of including demonstrate kidney study, we be
into such Flex, is the As efficacy decade. dialysis growth our a a may FLOW study as to neutral up case, base net the GLP-X volume ramps in over reminder, demonstrated adoption impact already be incorporated next that
for growth of revenue our financial XXXX. to of results. from returns our guidance This reflecting midpoint progress range This incorporates We're continued predictable of adjusted in guidance EPS investment a of care resilience each delivering despite the income business cycle respective growth and Shifting X%, and IKC. while external guidance XX% environment, our and metric. our operating strong for our more operating provide high-quality further of adjusted demonstrates setting to the ability, challenges, expectations
on forecast. me drivers Let a touch our of few
to XXXX, of center Mircera including income benefit from First, to full will related improvement, development our savings cycle transition XXXX of operating consolidation. positive annualization revenue in the year adjusted and our impact the
earnings business demonstrating from Second, progress continue factors higher share breakeven rate. XXXX. effective and to finally, program, line, IKC as expect noted, interest adjusted repurchase tax including OI will by below our other per other share offset by we're higher losses, the expense benefit and our in And
opportunity the turn we drive page we care. have As that within differentiate operating further to XXXX, to great a advancements DaVita kidney
performance it more and turn our discuss detail. now over Joel in I'll to outlook financial to